With marijuana legalisation sweeping the US, an increasing number of people believe that "weed" is the safest recreational drug, and carries health benefits that outweigh its risks.
However, according to a new study, each marijuana formulation may affect and sometimes even compromise the cardiovascular system in older adults.
"Marijuana can be a useful tool for many patients, especially for pain and nausea relief. At the same time, like all other medications, it does carry risks and side effects," said Alexandra Saunders from the Dalhousie University in Canada.
The study, published in the Canadian Journal of Cardiology, examined the case of a patient who developed crushing chest pain and myocardial ischemia after consuming most of a marijuana lollipop.
The "inappropriate dosing and oral consumption of marijuana resulted in distress that caused a cardiac event and subsequent reduced cardiac function," Saunders said.
The report describes a 70-year-old man with stable coronary artery disease, taking the appropriate cardiac medications, who ate most of a lollipop that was infused with 90 mg of THC (delta-9-tetrahydrocannabinol) to relieve pain and aid sleep. The lollipop caused him to have a potentially serious heart attack.
According to the report, he consumed a much larger dose than the 7 mg that is typically ingested by smoking a single joint or taking the 2.5 mg starting dose of a synthetic THC.
The patient's ingestion of an unusually large amount of THC caused the unexpected strain on his body from anxiety and fearful hallucinations and likely triggered the cardiac event, the researchers said.
A number of prior case reports, as well as epidemiological studies, have described the association between cannabis use and acute cardiovascular adverse events, including myocardial infarction, stroke, arrhythmias and sudden death.
While previous research on marijuana-induced myocardial ischemia has mostly focused on younger patients, healthcare providers need to understand and manage cannabis use and its complications in older patients, particularly in those with cardiovascular disease, the researchers noted.
--IANS
rt/rtp/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
